2019
DOI: 10.1016/j.preghy.2019.05.001
|View full text |Cite
|
Sign up to set email alerts
|

CXCL9/CXCL10 angiostasis CXC-chemokines in parallel with the CXCL12 as an angiogenesis CXC-chemokine are variously expressed in pre-eclamptic-women and their neonates

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
12
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 19 publications
(13 citation statements)
references
References 51 publications
0
12
0
Order By: Relevance
“…ELR-CXC chemokines including CXCL10 and CXCL12 serve as pro-migratory agents of peripheral blood mononuclear cells (PBMC) such as lymphocytes, monocytes and natural killer (NK) cell types [13,14]. CXCL10 chemokine, known as interferon γ (IFN-γ)-inducible protein 10 (or IP-10) was initially discovered as an IFN-γ-induced protein produced by a wide spectrum of cell types varying from endothelial cells [15], monocytes [16,17], keratinocytes [18], neutrophils [19], dendritic cells [20] and fibroblasts [21] to hepatocytes [22], and mesenchymal cells [23,24]. The common but not specialized receptor for CXCL10 is CXCR3 [25].…”
Section: Introductionmentioning
confidence: 99%
“…ELR-CXC chemokines including CXCL10 and CXCL12 serve as pro-migratory agents of peripheral blood mononuclear cells (PBMC) such as lymphocytes, monocytes and natural killer (NK) cell types [13,14]. CXCL10 chemokine, known as interferon γ (IFN-γ)-inducible protein 10 (or IP-10) was initially discovered as an IFN-γ-induced protein produced by a wide spectrum of cell types varying from endothelial cells [15], monocytes [16,17], keratinocytes [18], neutrophils [19], dendritic cells [20] and fibroblasts [21] to hepatocytes [22], and mesenchymal cells [23,24]. The common but not specialized receptor for CXCL10 is CXCR3 [25].…”
Section: Introductionmentioning
confidence: 99%
“…CXCL1 and CXCL12 both exhibit angiogenesis, activities whereas, CXCL9 and CXCL10 have antiangiogenesis properties and display angiostasis activities [19][20][21]. CXCL9 and CXCL10 exert their functions via binding to CXCR3 (a specific receptor for CXCL9 and CXCL10) [22,23]. In an almost similar mode of expression as CXCL10, the CXCL9 is also similarly expressed by a broad range of cell types in response to some members of cytokine family including, IFN-α/β and IFN-γ [24].…”
Section: Introductionmentioning
confidence: 99%
“…It has been shown that in the plasma of PE women the levels of CXCL9 and CXCL10 are increased, in line with the increase in IFN‐γ 59 . Similarly CXCL9 has been shown to increase in the PE placenta while CXCL10 was unaffected 60 …”
Section: Chemokines and Pementioning
confidence: 89%
“…59 Similarly CXCL9 has been shown to increase in the PE placenta while CXCL10 was unaffected. 60 Collectively, these findings suggest that the CXC chemokines may contribute to the inflammatory pathogenesis of PE and may present good therapeutic targets.…”
Section: Chemok Ine S and Pementioning
confidence: 94%